568 studies found for:    received in the last 14 days
Show Display Options
Rank Status Study
21 Not yet recruiting Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study
Conditions: Anxiety;   Depression;   Personality Disorders;   Trauma and Stress-related Disorders;   Somatic Disorders;   Obsessive Compulsive Disorders;   Eating Disorders;   Difficulties With Cognitive Emotion Regulation
Interventions: Behavioral: Cognitive Restructuring;   Device: rTMS;   Device: Sham rTMS
22 Not yet recruiting Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
Condition: Asthma
Interventions: Drug: dupilumab SAR231893/REGN668;   Drug: placebo;   Drug: fluticasone propionate and salmeterol;   Drug: budesonide and formoterol;   Drug: mometasone furoate and formoterol
23 Not yet recruiting Recovery of Hibernating Myocardium in End Stage Heart Failure
Conditions: Myocardial Function After LVAD Implant;   Ischemic Cardiomyopathy
24 Active, not recruiting The Effect of Breakfasts Varying in Protein Source on Appetite and Energy Intake
Condition: Obesity
Intervention: Dietary Supplement: Breakfasts varying in protein source content on appetite
25 Not yet recruiting A Study of the Safety, Tolerability, and Immunogenicity of V114 Compared With Prevnar 13™ in Healthy Adults 65 Years of Age or Older Previously Vaccinated With 23-valent Pneumococcal Polysaccharide Vaccine (V114-007)
Condition: Pneumococcal Infections
Interventions: Biological: V114;   Biological: Prevnar 13™
26 Not yet recruiting Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Schizophrenia/Schizoaffective Disorder
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Genetic: GeneSight Psychotropic (GEN);   Genetic: Enhanced-GeneSight Psychotropic (E-GEN);   Other: Treatment as Usual (TAU)
27 Not yet recruiting Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects
Conditions: Asthma (Part 1);   COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 μg (Part 1);   Drug: Dose 2, AZD8871 100 μg (Part 1);   Drug: Dose 3, AZD8871 300 μg (Part 1);   Drug: Dose 4, AZD8871 600 µg (Part 1);   Drug: Dose 5, AZD8871 1200 µg (Part 1);   Drug: Dose 6, AZD8871 1800 μg (Part 1);   Drug: Placebo, AZD8871 placebo (Part 1);   Drug: Treatment A, AZD8871 dose A (Part 2);   Drug: Treatment B, AZD8871 dose B (Part 2);   Drug: Treatment C, Indacaterol 150 μg (Part 2);   Drug: Treatment D, Tiotropium 18 μg (Part 2)
28 Not yet recruiting Integrated Child Obesity Treatment Study: Bull City Healthy and Fit
Condition: Childhood Obesity
Interventions: Behavioral: Bull City Healthy and Fit;   Behavioral: Healthy Lifestyles Clinic
29 Recruiting Impact of Treatment of Periodontis on Endothelial Function in Patients With Obstructive Sleep Apnea
Condition: Cardiovascular Disease in Obstructive Sleep Apnea
Intervention: Procedure: scaling and root planing
30 Active, not recruiting Air Pollution and Lipids Metabolic Disorder
Condition: Lipids Metabolic Disorder
31 Active, not recruiting Sealing Manifest Occlusal Caries Lesions in the Permanent Dentition
Condition: Dental Caries
Interventions: Procedure: Non-invasive resin based fissure sealing;   Procedure: Invasive resin based restoration
32 Recruiting An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
Conditions: Hyponatremia;   Syndrome of Inappropriate ADH (SIADH) Secretion;   Cancer
33 Recruiting Termination Of Anembryonic Pregnancy
Condition: Missed Abortion
Interventions: Drug: Misoprostol;   Drug: Isosorbide mononitrate;   Other: placebo
34 Not yet recruiting Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
Condition: Choroidal Neovascularization in Angioid Streaks
Intervention: Drug: Aflibercept
35 Recruiting A Bioequivalence Study of Peginterferon (PEG-IFN) Alfa-2a Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys®) Following Subcutaneous Administration
Condition: Hepatitis C
Interventions: Drug: PEG-IFN alfa-2a BA-free formulation;   Drug: PEG-IFN alfa-2a market formulation
36 Not yet recruiting Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo matched to prednisone;   Drug: Prednisone;   Biological: Tocilizumab
37 Recruiting Incidence and Risk Factors for Hospitalization-Associated Disability
Conditions: Functional Decline;   Hospitalization-associated Disability;   Iatrogenic Disease
Intervention: Procedure: Not applicable (observational design)
38 Recruiting A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
Condition: Scabies
Intervention: Drug: Permethrin
39 Not yet recruiting Physiologic Interactions Between the Adrenal- and the Parathyroid Glands
Conditions: Secondary Hyp;   Vitamin D Deficiency
Interventions: Drug: Valsartan;   Drug: Placebo Valsartan;   Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo cholecalciferol
40 Not yet recruiting A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients
Conditions: Human Immunodeficiency Virus;   Dolutegravir;   Monotherapy;   Treatment Efficacy
Intervention: Drug: Dolutegravir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years